Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (310K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Stepchenko, A. G.
Right arrow Articles by Pankratova, E. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stepchenko, A. G.
Right arrow Articles by Pankratova, E. V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1997 Oxford University Press 2847-2853

Cysteine 50 of the POUH domain determines the range of targets recognized by POU proteins

Cysteine 50 of the POU H domain determines the range of targets recognized by POU proteins Alexander G. Stepchenko*, Nadya N. Luchina and Elizaveta V. Pankratova

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 32 Vavilov str., 117984 Moscow, Russia

Received March 26, 1997; Revised and Accepted June 4, 1997

ABSTRACT

The best target of POU proteins (Oct-1, Oct-2) is an octamer sequence ATGCAAAT. POU proteins also recognize, with weaker affinity, the TAAT-like targets of another group of regulatory factors, the homeoproteins. Up to now, it has not been known why Cys50 of the POUH domain is absolutely conserved in contrast to that in homeoproteins. To assess the importance of Cys50 in determining the binding specificity of POU proteins, all possible amino acids were substituted for Cys at position 50, and the resulting mutants were tested with probes containing octamer (ATGCAAATNN) or homeospecific binding sites. Only the wild-type POU was shown to adequately discriminate between the octamer and homeospecific sites, and the protein affinity was only slightly affected by the nucleotide sequence flanking the octamer at the 3'-end. Any amino acid substitution at position 50 resulted in the mutant protein binding efficiently both to the octamer and the TAAT-like sequences. Moreover, in this case the 3'-flanking sequences influenced the binding to a much greater extent.

INTRODUCTION

In vertebrates, POU proteins are involved in regulation of transcription at different stages of development (1 -3 ). An octamer motif ATGCAAAT is the recognition site of POU proteins Oct-1 and Oct-2. This sequence is found in the regulatory regions of the snRNA and histone H2B genes, promoters of immunoglobulin genes and replication origins of SV40 and Ad4 (4 -9 ). Activation of gene promoters containing the octamer sequence required, in some cases, association of a B-cell-specific cofactor OBF-1 (Bob1, OCA-B) (10 -12 ) with Oct-1 and Oct-2 or general transcription factors (TBP and TFIIB). This association would restrict the POU protein-DNA recognition and gene transcription (13 ,14 ). POU proteins also bind to the `degenerate octamer' motif ATGCTAATGARAT or to the TAATGARAT sequence (15 -17 ) containing the POUH domain binding site TAATGA (18 -23 ). The conserved residues Val47 and Asn51 located in the third helix of the POUH domain make base-specific contacts in the DNA major groove, thus recognizing the 3'-half of the octamer binding site ATGCAAAT. The residues in the N-terminal arm of the POU homeodomain may form additional bonds in the minor groove (19 ,24 ). Genetic and biochemical studies of homeoproteins show that the variable residue at position 50 contacts with bases flanking the TAAT core at the 3' end and plays the key role in determining the binding specificity (25 -30 ). In contrast to the homeoproteins, residue 50 of the POUH domain is highly conserved. X-ray analysis revealed that Cys50 in the Oct-1 POUH domain made van der Waals contacts with methyl groups of thymines 3'-flanking the octamer site (24 ). On the other hand, site selection experiments demonstrated only a slight preference of the POU protein for thymine or adenine at position 9 and adenine at position 10 in the binding site ATGCAAATT/AA (19 ,31 ). Moreover, it was shown that the C50Q substitution has a little effect on the Pit-1 POUH domain affinity to DNA (32 ).

At present, it remains unknown why Cys50 is absolutely conserved in POU proteins. We have proposed that this residue restricts the range of potential POU protein targets. It is possible that evolutionary selection of transcription factors has been aimed both at increasing the affinity to their `own' targets and decreasing that to'foreign' DNA-binding sites. This is partly true for the families of transcription factors with homologous DNA-binding domains, such as homeoproteins and Pax proteins.

This work reveals the role of residues at position 50 of the POUH domain in recognizing the octamer (ATGCAAATNN) or homeospecific (TAATNN) binding sites.

MATERIALS AND METHODS

Construction of expression plasmids and purification of proteins

The cDNA fragment (amino acids 179-392) (33 ) containing the POU domain was cloned in the pUR292 expression vector between the BamHI and HindIII sites for introduction into Escherichia coli BMH 71-18 (20 ). The cells were grown to an OD600 of 0.3 in LB medium, then IPTG was added to 0.5 mM. Following 2 h of induction, bacterial cells were harvested by centrifugation and resuspended in 6 vol of a buffer (10 mM Tris-HCl pH 8.0, 10 mM EDTA, 1 mM PMSF and 0.2 mg/ml lysozyme), incubated for 20 min at 0oC, and freeze-thawed in the presence of 0.1% NP-40. Bacterial debris and nucleic acids were pelleted by centrifugation. Proteins were precipitated with ammonium sulphate at 35% saturation, collected by centrifugation, resuspended in PBS containing 1 mM DTT, 1 mM PMSF and dialyzed against the same buffer. Then the protein solution was passed through a Sepharose 2B column with immobilized on rabbit polyclonal antibodies against total E.coli BMH 71-18 proteins. The flow-through was collected and dialyzed against 100 mM KCl, 40 mM Tris-HCl pH 7.8, 1 mM EDTA, 1 mM DTT, 1 mM PMSF and 50% glycerol. Protein concentration and purity were determined by SDS-PAGE electrophoresis. Increasing amounts of highly purified wild-type POU protein were loaded on the gel for determining concentration of mutant proteins. Gel was stained with Coomassie blue G-250 and scanned by laser densitometer. Absorbtion of the bands corresponding the wild-type POU protein was plotted as a function of protein amount (calibration curve). Amount of undegradated C50K POU protein was determined according to the calibration curve.

Site-directed mutagenesis

Phage DNA preparation and mutagenesis were performed with the Pharmacia Oligonucleotide-Directed in vitro Mutagenesis System, using two mutagenic oligonucleotides: 5'-GGTTGCAGAACCAGACTTTGATCACTTCCTTCTCC-3' (R46) and 5'-GTTCTGGCGCCGGTTNNNGAACCAGACGCGGATCAC-3' (C50). The first was used to replace Arg46 of the POUH domain with Lys, and the second one for substitution of other amino acids for Cys50 (N is A, G, T or C). Mutations were identified by dideoxy sequencing.

Oligonucleotides

Two sets (`TAAT' and `OCT') of 35 bp oligonucleotides were synthesized to assay the DNA binding of the wild-type and mutant POU proteins. 1234567

TAAT5"-AGGTACCTGAGTTGATAATNAGACTGTCTCTAGAG-3" group 15"-AGGTACCTGAGTTGATAATGNGACTGTCTCTAGAG-3" group 2 12345678910OCT5"-AGGTACCTGAGATGCAAATNNGACTGTCTCTAGAG-3"

Each group of the `TAAT' nucleotide set consisted of four oligonucleotides with A, T, G or C at position 6 or 7 (groups 1 and 2, respectively). `OCT' probes contained 16 oligonucleotides with two randomized nucleotides downstream of the octamer site ATGCAAATNN. The flanking sequences were identical and did not contain additional TAAT and ATGC to obviate their effect on probe binding.

Gel retardation essay

Binding reaction was performed as described earlier (21 ). The amount of free DNA was plotted as a function of the log of POU domain concentration (Fig. 1 ). In the presence of excess protein, the relative dissociation constant was determined as the protein concentration required for binding 50% of the DNA probe, and normalized to that for the wild-type protein binding to the octamer site ATGCAAATGA.


Figure 1. Analysis of DNA-protein complexes by gel retardation. (A) Labelled oligonucleotide was incubated with increasing amounts of C50N POU mutant protein; (0) control DNA probe without protein. Positions of the protein-DNA complex and free DNA are indicated. (B) Quantitation of the gel retardation assay. The amount of free DNA was plotted as a function of the log of protein concentration. The relative affinity of protein to octamer probe (ATGCAAATGA) was determined as described in Materials and Methods.

Methylation and ethylation interference assay

Labeled DNA fragments were methylated with DMS by the method of Siebenlist and Gilbert (34 ). Modification of DNA with DEPC was performed according to Sturm et al. (35 ). The binding reaction was carried out as described earlier (21 ), except that the samples contained 1-5 [mu]g polyd(G[middot]C)[middot]polyd(G[middot]C) and 1-3 ng of modified DNA as a probe. Free and protein-bound DNA fragments were located by autoradiography, eluted from the gel, and further processed as described earlier (34 ). The cleavage products were resolved in 7% sequencing gel and quantitated by scanning the autoradiograph with a laser densitometer.

RESULTS

Interaction of the wild-type POU domain with homeospecific binding sites TAATNN and octamer sequences ATGCAAATNN

The effect of nucleotide substitutions in the homeospecific binding site TAATNN on the affinity of the Oct-2 POU domain was estimated in the gel retardation assay (Fig. 1 A). The equilibrium dissociation constant of the protein-DNA complex was determined at constant concentration of the DNA probe and increasing concentration of the POU domain (Fig. 1 B). As seen in Table 1 , adenine at position 7 and guanine or thymine at position 6 are favored by the wild-type POU, and TAATG/TA is the optimal homeospecific binding site. With other nucleotides at these positions, the affinity is about one-quarter. The variation in the dissociation constant, upon substitution of nucleotides 3'-flanking the homeospecific binding site can be characterized with a dispersion coefficient Disp H = Rel.Kd H max/Rel.Kd H min, where Rel.Kd H max and Rel.Kd H min are the maximum and the minimum relative dissociation constants. For the wild-type POU domain, Disp H = 3.9. The small dispersion may be explained by the fact that Cys50 of the POU domain forms no contacts with nucleotides 3'-flanking the homeospecific binding site TAATNN, or their contribution to the DNA-protein complex stability is insignificant. To test these possibilities, the contacts between the POU domain residues and nucleotides of the optimal binding site ATAATGA were mapped in interference experiments (Fig. 2 A). Ethylation and methylation of A3 and A4 in the top strand, and A2 in the bottom strand, as well as ethylation and methylation of A5 in the bottom strand, interfered with the POU domain binding. Ethylation or methylation of the nucleotides 3'-flanking the TAAT core had no effect.


Figure 2. Ethylation and methylation interference experiments with the wild-type POU domain. (A) and (B), homeospecific and octamer sequences, respectively, used for interference experiments; E, DNA modified with DEPC; M, DNA modified with DMS; [alpha] and [beta] are top and bottom DNA strands, respectively; 1, reference lane, G + A sequencing reaction; 2, free DNA; 3, DNA isolated from DNA-protein complex. The sequence of the interference region is shown on the right. The contacts are summarized under autoradiograph. Bases modified by DMS or DEPC that interfere strongly (>4-fold reduction of intensity) are marked by closed circles or diamonds, respectively, and the ones that interfere weakly (2-4-fold) are indicated by open circles. Summary of the contacts are shown under the autoradiograms.

Table 1 . Binding of the wild-type POU domain and mutants with homeospecific sites
Homeospecific
site
Rel.Kda
wt POU
 
C50A
 
C50S
 
C50N
 
C50Q
 
C50K
ATAATGA 5.8 5.2 15 3.2 12.8 >200
ATAATGT 9.8 72 18 6.4 90 >200
ATAATGC 2.2 >110 4 4.2 48 15
ATAATGG 18.0 >110 19.2 60 32 >200
ATAATAA 16.4 78 38 46 112 64
ATAATTA 5.6 2.8 16.2 1.6 3.6 132
ATAATCA 10.2 26 28 28 80 16.2
ATAATCC 22.0 >110 42 >60 160 2.8
ATAATTT 6.4 2.7 11.6 2.6 4.6 180
Preferred TAATGA TAATTA TAATGC TAATTA TAATTA TAATCC
binding site(s) TAATTA TAATTT        
DispHb 3.9 >40 10.5 >38 44.4 >71
aRel.Kd values of the wild-type POU and mutant proteins were determined as described in Materials and Methods and normalized to that for the wild-type protein binding to the octamer site ATGCAAATGA.
bDispH, dispersion of Rel.Kd for homeospecific sites is equal to Rel.Kd H max /Rel.Kd H min.

Table 2 . Binding of the wild-type POU domain and mutants with octamer sequences ATGCAAATNN
Protein

Most preferred binding
site(s)
Rel.Kd oct min

Least preferred
binding site
Rel.Kd oct max

Disp octa

Kdiscrb

WT ATGCAAATTA 1.0 ATGCAAATCG 2.0 2.0 2.8
  ATGCAAATGA 1.0        
C50A ATGCAAATTA 0.8 ATGCAAATAG 1.9 2.4 1.4
  ATGCAAATTT 1.0        
  ATGCAAATGT 1.0        
C50S ATGCAAATGC 1.8 ATGCAAATCT 5.2 2.9 0.8
C50N ATGCAAATTT 0.8 ATGCAAATCG 2.6 3.3 0.6
  ATGCAAATTA 0.8        
C50Q ATGCAAATTA 0.7 ATGCAAATCC 4.6 6.6 0.8
C50K ATGCAAATCC 1.6 ATGCAAATGG 22.4 14.0 0.12
C50T ATGCAAATTA 0.8 ATGCAAATCT 3.8 5.4  
  ATGCAAATGC 0.7        
  ATGCAAATGT 0.8        
C50V ATGCAAATGT 1.6 ATGCAAATCC 11.6 7.3  
C50M ATGCAAATTC 2.6 ATGCAAATAG 28.0 10.8  
C50H ATGCAAATTC 4.8 ATGCAAATGG 32.0   6.7
aDispersion of Rel.Kd value for octamer sequences (ATGCAAATNN) is equal to Rel.Kd oct max/Rel.Kd oct min. bCoefficient of discrimination is equal to Rel.Kd H min/Rel.Kd oct max.

In interference experiments of the wild-type POU protein with octamer sequence ATGCAAATGA (Fig. 2 B) methylation of A5, A6 and A7 at the top strand and G4 at the bottom strand abolish the binding. Ethylation of A1, A5, A6 and A7 at the top strand and A2, G4 and A8 at the bottom strand interfered with POU domain binding. As with the homeospecific site, ethylation or methylation of nucleotides 3'-flanking the octamer site did not prevent the binding.

The wild-type POU protein affinity for decamers ATGCAAATNN only slightly depended on the 3'-flanking nucleotides (Table 2 ). This suggests that the nucleotides 3'-flanking both the TAAT and octamer sites do not directly contact the POUH Cys50. The effect of 3'-flanking nucleotides on the protein binding is more pronounced with homeospecific sites than with octamer sequences. This finding is in good agreement with the results of other researchers (19 ,31 ,36 ).

Binding of mutated POU proteins to homeospecific and octamer sites

Cysteine at position 50 was substituted by other amino acids, and mutant proteins were assayed with homeospecific ATAATNN and octamer ATGCAAATNN sites. As seen in Table 1 , only five out of 19 residues (Ala, Lys, Asn, Gln and Ser) sustain the DNA-binding ability. The C50R POU mutant stands apart because of its very relaxed specificity to homeo sites. All nucleotide substitutions in the homeospecific site at any position from 1 to 7 are allowed without a dramatic decrease in the affinity (relative dissociation constants are 5-35). So, all mutants still capable of interacting with homeo sites have higher affinity to their optimal sites, and a wider range of dispersion as compared with the wild-type POU (Table 1 ). Thus, it is quite reasonable to suggest that the residues at position 50 of the mutant POU homeodomains are in closer contact with the nucleotides 3'-flanking the TAAT core, and these proteins recognize homeospecific sites in a manner similar to the homeoproteins. To check this assumption, ethylation and methylation experiments were performed (Fig. 3 ). Under the autoradiograph we have summarized all contacts thus identified. Other POU mutants C50S, C50Q and C50K have very similar methylation and ethylation patterns (data not shown). Like the wild-type POU (Fig. 2 A), methylation and ethylation of A2 and A3 at the top strand and A1 at the bottom strand as well as ethylation of A4 at the bottom strand interfered with mutant protein binding. In contrast to the wild-type POU, ethylation of nucleotides at positions 6 and 7 interfered with the mutant protein binding as well as ethylation and methylation of adenine at position -1.


Figure 3. Ethylation and methylation interference experiments with POU C50A (A) and POU C50N (B) mutants. Designations as Figure 2.

To what extent does the affinity of mutated POU proteins depend on the nucleotides 3'-flanking the octamer site? To answer this question, we examined their binding to decamer sequences ATGCAAATNN and determined the relative dissociation constants (Table 2 ). All mutants that interact with the homeospecific sites are also capable of binding to decamers, but in the latter case the manner of interaction is essentially different. The peculiarity is that the 3'-flanking nucleotides affect binding with the octamer to a lesser extent than with homeospecific sites, while the range of dispersion for any mutant is wider than for the wild-type protein. Only the C50A mutant has no clear preference for any bases at positions 9 and 10 (Table 2 and Fig. 4 ). The sequences of choice for binding with C50N, C50Q, C50K and C50S POU mutants are ATGCAAATTT/A, ATGCAAATTA, ATGCAAATCC and ATGCAAATGC, respectively. Although C50T, C50V, C50M and C50H mutants do not efficiently interact with homeospecific sites, their affinity to octamer sequences is highly dependent on the 3'-flanking nucleotides (Table 2 ).


Figure 4. The role of residue 50 of the POUH domain in selection of homeospecific (TAAT) and octamer (ATGCAAAT) sequences. The bar height is the relative Kd (Rel.Kd) value of a given protein binding with an octamer sequence flanked by nucleotides denoted at the horizontal axis. The area is naturally divided into two parts characteristic of the alternative targets: octamer and homeospecific sites, oct and homeo-zones, respectively. The bottom boundary of the homeo-zone (shaded) corresponds to a minimum relative Kd value for homeospecific binding sites, normalized to that of the wild-type POU protein to octamer site ATGCAAATGA (see Table 1). The top boundary of the oct-zone is determined by the maximum relative Kd value for oct sequences. Lack of discrimination between the two types of sequences (C50Q and C50K mutants) result in overlapping between the two zones. In the case of sharply defined discrimination the zones do not overlap (wild-type POU and C50A mutant) and the degree of discrimination is characterized by the coefficient of discrimination (Kdiscr) in Table 2.

DISCUSSION

Our experimental results and data in the literature (18 ,19 ,21 ,31 ,37 ) suggest that the wild-type POU domain has the following DNA-binding properties: (i) the affinity to the octamer sequence is high and only slightly depends on the 3'-flanking nucleotides; (ii) the wild-type POU domain can recognize homeospecific sites containing the TAAT core, but with a weaker affinity. Cys50 of the POUH domain is not in close proximity to the nucleotides 3'-flanking the binding sites (Fig. 2 ), but in the case of homeospecific sequences these nucleotides significantly affect the protein affinity (Table 1 ). In the case of the octamer site this effect is slight. Why does Cys50 of the POU proteins not contact with the nucleotides 3'-flanking the octamer sequence? This is apparently caused by two reasons. First, the ability of the POU domain to bend DNA (38 ), may result in the removal of Cys50 from the 3'-flanking nucleotides and relief of internal stresses. The second reason is formation of a hydrogen bond between the SH group of Cys50 and the carbonyl oxygen of the highly conserved Arg46 (24 ). This bond may alter the Cys50 orientation relative to the 3'-flanking nucleotides. Homeoproteins do not have Cys at position 50, and Lys occupies position 46 in most cases. A hydrogen bond between positions 46 and 50 in homeoproteins may only be formed if Gln50 of even-skipped homeodomain is in non-canonical conformation (30 ). To assess the mutual effect of residues 46 and 50, we examined the DNA-binding properties of R46K POU mutant. This amino acid substitution not only reducted the affinity to both TAAT and octamer sites about 10 times and changed of the optimal binding site (ATGCAAATGT) but also increased the dispersion to 3.1 (not shown). Is Cys50 alone able to define the unique specificity of the POU protein binding to DNA? Six residues (Ala, Asn, Gln, Ser, Lys and Arg) out of the 19 tested can replace Cys50 retaining the POU domain ability to bind to homeospecific sites. In all cases the affinity of mutated proteins to their optimal binding sites is higher than that of the wild-type POU domain to its preferred homeospecific sites TAATG/TA (Table 1 ). For mutants but not for the wild-type POU protein, ethylation of nucleotides 3'-flanking the TAAT core interfered with binding (Fig. 2 ). The ethylation and methylation patterns are similar to those of classical homeoproteins (28 ), and the optimal binding sites for C50A, C50Q and C50K POU proteins coincide with the corresponding sites for homeoproteins (27 ,29 ,39 ) (Fig. 3 and Table 1 ).

We believe that Cys50 defines the manner of the POUH domain interaction. With Cys at this position, the POUH domain follows the `POU' interaction pattern, and this residue is not involved in recognition of the 3'-flanking nucleotides. When Cys50 is replaced by any amino acid except Arg, the POU domain-DNA binding follows the `homeo' pattern. In this case the mutants, like classical homeoproteins, are capable of specific and high-affinity binding to homeospecific sites. Distinctions between the wild-type and the mutated POU domain are even more pronounced in their interaction with the octamer. As seen in Figure 4 only the wild-type POU domain is capable of adequately discriminating between the two types of target: the affinity for all octamer sequences is about three times higher than that for any homeospecific site. All mutants that bind to the TAAT core have significantly lower discrimination coefficients (Table 2 ). The oct- and homeo-areas in Figure 4 are either close to each other (C50A) or overlap (C50Q and C50K). Hence, such mutants bind homeospecific sequences as well as octamer sites. In contrast to them, the C50H, C50T, C50M and C50V mutants do not bind to TAAT-like sequences, but recognize the oct sites. All of them have high values of dispersion and hence efficiently bind to a limited number of potential octamer targets. Evolutionary selection adapts not only the POU proteins to their targets, but concurrently the targets to POU proteins. In this connection, it is noteworthy that there are two kinds of homeospecific sites with most affinity for wild-type POU protein, TAATGA and TAATTA (Table 1 ). The first one is a part of all TAATGARAT or ATGCTAATGARAT targets where the conserved GA are essential for POUH domain binding (18 ,22 ). The second one is not found in these natural targets. This is perhaps due to the fact that the latter is the high-affinity binding site for a wide number of Antp-family homeoproteins. Therefore, such proteins would compete with POU for TAATTARAT or ATGCTAATTARAT targets.

Thus, no residues at position 50 except Cys can give the POU proteins the capability of highly selective recognition of their specific targets and binding to them independently of the 3'-flanking nucleotides.

ACKNOWLEDGEMENTS

The authors are grateful to Prof. Oleg L.Polanovsky for valuable discussions; to Prof. Walter Schaffner (Institut fur Molecularbiologie II, der Universitat Zurich) for advice, and support in early stages of this work. Thanks are also due to Dr Rechinsky for critical reading of the manuscript and Elena Sytina and Viktor Petukhov for assistance. This work was supported by the Russian Human Genome program, the Russian State program `Frontiers in Genetics' and International Science Foundation (grants N26000 and N263000).

REFERENCES

1 Ruvkun,G. and Finney,M. (1991) Cell 64, 475-478. MEDLINE Abstract

2 Rosenfeld,M.G. (1991) Genes Dev. 5, 897-907. MEDLINE Abstract

3 Verrijzer,C.P. and van der Vliet,P.C. (1993) Biochim. Biophys. Acta 1173, 1-21. MEDLINE Abstract

4 Lebowitz,P. and Ghosh,P.K. (1982) J. Virol. 41, 449-461. MEDLINE Abstract

5 Topol,J., Ruden,D.M. and Parker,C.S. (1985) Cell 42, 527-537.

6 McKnight,S. and Tjian,R. (1986) Cell 46, 795-805. MEDLINE Abstract

7 Falkner,F.G. and Zachau,H.G. (1984) Nature 310, 71-74.

8 Banerji,J., Olson,L. and Schaffner,W. (1983) Cell 33, 729-739.

9 Muller,M.M., Ruppert,S., Schaffner,W. and Matthias,P. (1988) Nature 336, 545-550.

10 Strubin,M., Newell,J.M. and Matthias,P. (1995) Cell 80, 497-506. MEDLINE Abstract

11 Gstaiger,M., Knoepfel,L., Georgiev,O., Schaffner,W. and Hovens,C.M. (1995) Nature 373, 360-362. MEDLINE Abstract

12 Luo,Y. and Roeder,R.G. (1995) Mol. Cell. Biol. 15, 4115-4124. MEDLINE Abstract

13 Schubart,D.B., Sauter,P., Massa,S., Friedl,E.M., Schwarzenbach,H. and Matthias,P. (1996) Nucleic Acids Res. 10, 1913-1920.

14 Gstaiger,M., Georgiev,O., van Leeuwen,H., van der Vliet,P.C. and Schaffner,W. (1996) EMBO J. 11, 2781-2790.

15 O'Hare,P. and Goding,C.R. (1988) Cell 52, 435-445. MEDLINE Abstract

16 Baumruker,T., Sturm,R. and Herr,W. (1988) Genes Dev. 2, 1400-1413. MEDLINE Abstract

17 apRhys,C.M.J., Ciufo,D.M., O`Neill,E.A., Kelly,T.J. and Hayward,G.S. (1989) J. Virol. 63, 2798-2812.

18 Verrijzer,C.P., Kal,A.J. and van der Vliet,P.C. (1990) Genes Dev. 4, 1964-1974. MEDLINE Abstract

19 Verrijzer,C.P., Alkema,M.J., van Weperen,W.W., van Leeuwen,H.C., Strating,M.J.J. and van der Vliet,P.C. (1992) EMBO J. 11, 4993-5003. MEDLINE Abstract

20 Stepchenko,A.G. (1992) Doklady Akademii. Nauk, RUSSIA, 235, 175-178.

21 Stepchenko,A.G. (1994) FEBS Lett. 337, 175-178.

22 Douville,P., Hagmann,M., Georgiev,O. and Schaffner,W. (1995) Virology 207, 107-116. MEDLINE Abstract

23 Wey,E. and Schafer,B.W. (1996) Biochem. Biophys. Res. Commun. 2, 274-279.

24 Klemm,J.D., Rould,M.A., Aurora,R., Herr,W. and Pabo,C.O. (1994) Cell 77, 21-32. MEDLINE Abstract

25 Kissinger,C.R., Liu,B., Martin-Blanco,E., Kornberg,T.B. and Pabo,C.O. (1990) Cell 63, 579-590. MEDLINE Abstract

26 Hanes,S.D. and Brent,R. (1989) Cell 57, 1275-1283. MEDLINE Abstract

27 Treisman,J., Gonczy,P., Vashishtha,M., Harris,E. and Desplan,C. (1989) Cell 59, 553-562. MEDLINE Abstract

28 Percival-Smith,A., Muller,M., Affolter,M. and Gehring,W.J. (1990) EMBO J. 9, 3967-3974. MEDLINE Abstract

29 Ades,S.E. and Sauer,R.T. (1994) Biochemistry 33, 9187-9194. MEDLINE Abstract

30 Hirsch,J.A. and Aggarwal,A.K. ( 1995) EMBO J. 14, 6280-6291.

31 Pomerantz,J.L. and Sharp,P.A. (1994) Biochemistry 33, 10851-10858. MEDLINE Abstract

32 Ingraham,H.A., Flynn,S.E., Voss,J.W., Albert,V.R., Kapiloff,M.S., Wilson,L., and Rosenfeld,M.G. (1990) Cell 61, 1021-1033. MEDLINE Abstract

33 Clerc,R.G., Corcoran,L.M., LeBowitz,J.H., Baltimore,D. and Sharp,P.A. (1988) Genes Dev. 2, 1570-1581. MEDLINE Abstract

34 Siebenlist,U. and Gilbert,W. (1980) Proc. Natl. Acad. Sci. USA 77, 122-126. MEDLINE Abstract

35 Sturm,R., Baumruker,T., Franza,B.,Jr and Herr,W. (1987) Genes Dev. 1, 1147-1160. MEDLINE Abstract

36 Brugnera,E., Xu,L., Schaffner,W. and Arnosti,D. (1992) FEBS Lett. 314, 361-365. MEDLINE Abstract

37 Botfield,M.C., Jancso,A. and Weiss,M.A. (1994) Biochemistry 33, 8113-8121. MEDLINE Abstract

38 Verrijzer,C.P., van Oosterhout,J.A.W.M., van Weperen,W.W. and van der Vliet,P.C. (1991) EMBO J. 11, 3007-3014.

39 Scott,M.P., Tamkun,J.W. and Hartzell,G.W. (1989) Biochim. Biophys. Acta 989, 25-48. MEDLINE Abstract


*To whom correspondence should be addressed. Tel: +7 095 135 97 29; Fax: +7 095 135 14 05; Email: pol@genomii.eimb.rssi.ru
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Jacquemin, V. J. Lannoy, G. G. Rousseau, and F. P. Lemaigre
OC-2, a Novel Mammalian Member of the ONECUT Class of Homeodomain Transcription Factors Whose Function in Liver Partially Overlaps with That of Hepatocyte Nuclear Factor-6
J. Biol. Chem., January 29, 1999; 274(5): 2665 - 2671.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. J. Lannoy, T. R. Burglin, G. G. Rousseau, and F. P. Lemaigre
Isoforms of Hepatocyte Nuclear Factor-6 Differ in DNA-binding Properties, Contain a Bifunctional Homeodomain, and Define the New ONECUT Class of Homeodomain Proteins
J. Biol. Chem., May 29, 1998; 273(22): 13552 - 13562.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (310K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Stepchenko, A. G.
Right arrow Articles by Pankratova, E. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stepchenko, A. G.
Right arrow Articles by Pankratova, E. V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?